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ABSTRACT  
Amavatha is a disease caused due to the vitiation or aggravation of Vayu 
associated with Ama. Vitiated Vayu circulates Ama all over the body through 
Dhamanies and takes shelter in Sleshmastana (Amasaya, Sandhi etc), producing 
symptoms such as stiffness, swelling and tenderness in small and big joints. The 
symptoms of Amavatha are identical to rheumatoid arthritis and in common 
clinical practices it can be observed that there will be raised ESR value in 
conditions like Rheumatoid arthritis due to chronic inflammation. As and when 
the inflammation aggravates due to Ama, the ESR value does not come to the 
normal level. Various drug trials were already carried out on Amavatha, yet 
there is a lacuna in the management of Amavatha. As Pachana is considered as 
the first and for most treatment of Amavatha. A research was conducted to find 
out the Amapachana property of Sunthichurna in raised ESR associated with 
Amavatha. 30 patients were randomly selected from the outpatient department 
of Dravyagunavijnana, Govt Ayurveda college, Thripunthura. 2gm of Sunthi 
churna in divided dose were given to the patients before food with lukewarm 
water as Anupana for 30 days. The result showed significant decline in the 
severity of subjective symptoms like Angamarda (Pain on body parts), Aruchi 
(Anorexia), Alasya (Lethargy), Gourava (Heaviness), Apaka (Indigestion) and 
Sopha (Oedema) and there is a mild decrease in the value of ESR. The study 
revealed that the trial drug is effective in case of Amavatha. 
INTRODUCTION 
 Ayurveda, the ancient medical system 
and science of life can be considered as the art of healing 
and prolonged life. Philosophical and scientific base of 
Ayurveda is the rich house of hidden treasure of 
principles and practices. As per Ayurveda, the diseased 
state is the disturbance in the equilibrium of Dosha, 
Dhathu, and Mala. The right knowledge behind 
correction cannot be obtained without understanding 
the depth of pathology. Ama is an important factor in the 
pathology of any diseases[1]. In Ayurveda classics the 
word Ama represents a condition in which ingested food 
(Ahara) or functional principles of body (Doshas) 
produce vitiated  Ahara rasa in stomach (Amasaya) [2] 
and is considered as a root cause of disease. Amavatha is 
a diseased condition especially due to the involvement of 
Amadosha and Vatha[3]. The involvement of Ama and 
vitiated Vata, results in the inflammation of body parts 
which is an important sign in. In common clinical 
practice it can be observed that in conditions like 
Rheumatoid arthritis, there will be raised ESR value, as a 
result of chronic inflammatory process. As and when the 
inflammation aggravates due to Ama, the ESR value does 
not come to the normal level. Pachana is the first and 
foremost treatment of Ama recommended by Acharyas[4]. 
In Sarngadhara Samhitha the term Pachana is defined as 
the drug action (Karma) that digest Ama. Sunthi (Zingiber 
officinale Roxb) is a Pachana drug and is indicated in 
Amavatha and Sopha[5]. So a study was conducted to 
evaluate the Amapachana property of Sunthi in raised 
ESR associated with Amavatha. 
MATERIALS AND METHODS 
Objective: To evaluate the Amapachana property of 
Sunthichurna in Raised ESR conditions associated with 
Amavatha. 
Selection of cases: 30 patients from Out Patient 
Department of Government Ayurveda College, 
Tripunithura were selected randomly as per exclusion 
and inclusion criteria. 
Inclusion criteria 
 Age – Patients aged between 30 to 65 years  
 Diagnosed as Amavatha as per subjective criteria, 
with raised ESR value. 
 Men with ESR>20mm/hr  
 Women with ESR >30mm/hr  
 Exclusion Criteria 
 Diagnosed disorders like malignancy, gout, trauma 
T.B. and other connective tissue disorders and 
associated other systemic diseases.  
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 Unwilling patients  
  Hepatic or renal failure  
  Pregnant and lactating mother  
Study design: It was an interventional pre post test 
without control. 30 patients from Out Patient 
Department of Government Ayurveda College, 
Tripunithura were selected as per exclusion and 
inclusion criteria. Sunthichurna in the form of capsule 
had given internally in a dose of 2 gm per day (in divided 
dose of 1gm twice daily). Clinical evaluations according 
to subjective and objective criteria were done. Follow up 
was done after 45 days. 
Plan of intervention 
Drug: Sunthichoorna (powder of rhizome of Zingiber 
officinale).  
Form of Medication: Capsule  
Dose: 2capsule (each of 500mg) twice a day (morning 
and evening).  
Anupana: lukewarm water  
Time of administration: before food,  
Duration of study : 30days  
Period of study: 18months 
Preparation of medicine 
  The collected raw drugs were washed 
thoroughly, removed all earthy and foreign materials, 
chopped into small pieces, then dried properly and made 
into fine powder. Powdered drugs individually passed 
through sieve number 85 to prepare a fine powder. Then 
made in to capsule, each capsule contains 500mg of 
Sunthichurna. 
 
Assessment criteria  
The patients were assessed on the basis of subjective and 
objective criteria.  
Subjective criteria  
Subjective symptoms were assessed by the 
grading system. Scoring was done from 0 to 3 depending 
on the severity of symptoms (Grade 0 is the normal, 
Grade 1 is mild, Grade 2 is moderate and Grade 3 is 
severe in all the subjective criteria).  
Lakshana seen in the condition of Ama and in the disease 
Amavatha. 
 Angamarda (pain on the body parts)  
 Aruchi (Anorexia)  
 Thrishna (Thirst)  
 Aaalasya (Laziness)  
 Gourava (Heaviness)  
 Jwara (fever)  
 Apaka (Indigestion)  
 Sopha (Oedema)  
Objective criteria 
E.S.R (Westergren method)  
Statistical Analysis  
The result was Statistically analyzed using Wilcoxon test 
and paired t test.  
Study variable  
Study variables-age, economic status, nutritional status, 
educational status etc.  
Ethical clearance  
Ethical clearance was obtained from Institutional Ethical 
Committee(Dated 05/05/2015). 
OBSERVATION AND RESULTS 
Observations and results in the study were detailed in table 
Table 1: Distribution of Patients according to Clinical Symptoms 
Clinical Symptoms No: of Patients Percentage 
Angamarda 26 86.7% 
Aruchi 20 66.7% 
Thrishna 0 0.0% 
Alasya 11 36.7% 
Gourava 10 33.3% 
Jwara 0 0.0% 
Apaka 7 23.3% 
Sopha 14 46.7% 
Table 2: Change in Angamarda after Treatment 
Angamarda Before Treatment After Treatment Z – value 
Grade 0 0 (0.0%) 25 (83.3%) 
5.099** 
Grade 1 25 (83.3%) 1 (3.3%) 
Grade 2 1 (3.3%) 0 (0.0%) 
Grade 3 0 (0.0%) 0 (0.0%) 
** The change is significant at 0.01 level 
Table 3: Change in Aruchi after Treatment 
Aruchi Before Treatment After Treatment Z – value 
Grade 0 0 (0.0%) 20 (66.7%) 
4.472** 
Grade 1 20 (66.7%) 0 (0.0%) 
Grade 2 0 (0.0%) 0 (0.0%) 
Grade 3 0 (0.0%) 0 (0.0%) 
** The change is significant at 0.01 level 
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Table 4: Change in Alasya after Treatment 
Alasya Before Treatment After Treatment Z – value 
Grade 0 0 (0.0%) 11 (36.7%) 
3.317** 
Grade 1 11 (36.7%) 0 (0.0%) 
Grade 2 0 (0.0%) 0 (0.0%) 
Grade 3 0 (0.0%) 0 (0.0%) 
** The change is significant at 0.01 level 
Table 5: Change in Gourava after Treatment 
Gourava Before Treatment After Treatment Z – value 
Grade 0 0 (0.0%) 10 (33.3%) 
3.162** 
Grade 1 10 (33.3%) 0 (0.0%) 
Grade 2 0 (0.0%) 0 (0.0%) 
Grade 3 0 (0.0%) 0 (0.0%) 
** The change is significant at 0.01 level 
Table 6: Change in Apaka after Treatment 
Apaka Before Treatment After Treatment Z – value 
Grade 0 0 (0.0%) 7 (23.3%) 
2.646** 
Grade 1 7 (23.3%) 0 (0.0%) 
Grade 2 0 (0.0%) 0 (0.0%) 
Grade 3 0 (0.0%) 0 (0.0%) 
** The change is significant at 0.01 level 
Table 7: Change in Sopha after Treatment 
Sopha Before Treatment After Treatment Z – value 
Grade 0 0 (0.0%) 13 (43.3%) 
3.606** 
Grade 1 13 (43.3%) 0 (0.0%) 
Grade 2 1 (3.3%) 1 (3.3%) 
Grade 3 0 (0.0%) 0 (0.0%) 
** The change is significant at 0.01 level 
Objective criteria  
Table : 8 Change in ESR after Treatment 
ESR Mean SD t – value 
Before Treatment 51.73 19.56   
After Treatment 51.43 20.26 0.638NS 
After Follow up 50.27 20.51 1.672NS 
NS  The change is significant 
DISCUSSION  
Angamarda (pain on body parts): Out of 30 patients 
participated the study, most of the patients had 
Angamarda as a common symptom. Before treatment 
severity of the Angamarda reported as 1 patient (3.3%) 
had grade 2, 25 patients (83.3%) as grade 1. Here the p-
value is less than the significance level 0.01; indicating 
that the change in Angamarda after treatment is 
significant. The study reveals that 83.3% cases of grade 1 
is reduced to grade 0 and 3.3% cases of grade 2 is 
reduced to grade 1 after treatment. Angamarda is a main 
symptom of Amavatha. Here Srothorodha by Ama results 
in the vitiation of Vatha. As Sunthi is having both 
Pachana and Deepana action, Ama get digested and thus 
results in the Anulomana of Vatha. Katu rasa of the drug 
act as Srothosodhana. Laghuguna and Ushnaveerya of the 
drug is beneficial to increase digestive fire. Snigdaguna 
and Madhura vipaka of Sunthi will alleviate Vatha. 
Aruchi: Out of 30 patients participated the study, most of 
the patients had Aruchi as a common symptom. Before 
treatment severity of the Aruchi reported as 20 patients 
(66.7.%) as grade 1, Here the p-value is less than the 
significance level 0.01; the change in Aruchi after 
treatment is significant. The table shows that 66.7% 
cases of grade 1 Aruchi was seen before treatment and is 
reduced to grade 0 after treatment. Katu rasa of the drug 
act as Srothosodhana and Kaphahara. Ushnaveerya and 
Laghuguna of the drug also alleviate Kapha and 
Amadosha thus helps to alleviates Aruchi. 
Alasya: Out of 30 patients participated the study, most of 
the patients had Alasya as a common symptom. Before 
treatment severity of the Alasya reported as 11 patients 
(36.7%) as grade 1. Here the p-value is less than the 
significance level 0.01; the change in Alasya after 
treatment is significant. The table shows that 36.7% 
cases of grade 1 Alasya was seen before treatment and is 
reduced to grade 0 after treatment. As the drug Sunthi is 
having Srodhosodhana, Deepana and Pachana Property it 
works as an effective drug in Alasya. 
Gourava: Out of 30 patients participated the study, most 
of the patients had Gourava as a common symptom. 
Before treatment severity of the Gourava reported as 10 
patient (33.3%) as grade 1. Here the p-value is less than 
the significance level 0.01; the change in Gourava after 
treatment is significant. The table shows that 33.3% 
cases of grade 1 Gourava was seen before treatment and 
is reduced to grade 0 after treatment. Ama is the main 
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cause of Gourava. Srodhorodha due to Ama will manifest 
as Gourava. Pachana of Ama helps to retain the Laghutwa 
of the body 
Apaka: Out of 30 patients participated the study, most of 
the patients had Apaka as a common symptom. Before 
treatment severity of the Apaka reported as 7 patient 
(23.3%) as grade 1. Here the p-value is less than the 
significance level 0.01; the change in Apaka after 
treatment is significant. The table shows that 23.3% 
cases of grade1 Apaka as seen before treatment and is 
reduced to grade 0 after treatment. Deepana and 
Pachana property of Sunthi will alleviates Apaka. 
Sopha: Out of 30 patients participated the study, most of 
the patients had Sopha as a common symptom. Before 
treatment severity of the Sopha reported as 13 patient 
(43.3%) as grade 1, 1 patients (3.3%) as grade 2. Here 
the p-value is less than the significance level 0.01; the 
change in Sopha after treatment is significant. The table 
shows that 43.3% cases of grade 1 Sopha was seen 
before treatment and is reduced to grade 0 after 
treatment. The drug possesses Grahi property by which 
it act as Drava soshaka and it helps to reduce Sopha. 
ESR: Here both the p-values are greater than the 
significance level 0.05; the change in ESR after treatment 
is not significant. The table shows that the ESR is almost 
same before treatment (51.73 ± 19.56), after treatment 
(51.43 ± 20.26) and after follow up (50.27 ± 20.51). there 
is a mild decrease in ESR. As the disease is chronic 
inflammatory more time duration is needed for better 
result. 
CONCLUSION 
From the Clinical study, it can be summarized that 
the drug Sunthi (Zingiber officinale Roxb) showed 
significant result in reducing the subjective symptom, 
also, it showed a mild decrease in ESR value. This drug 
can be effectively administered in reducing the 
subjective symptoms of Amavatha. Since toxicity studies 
of the study drug were done early, the treatment can be 
administered safely. No adverse effect was observed 
during clinical trial.  
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